Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer. Sep 2011 - Head Neck; 33(10):1097-0347 [PMID:21928411] [Li P] [Chen CH] [Li S] [Givi B] [Yu Z] [Zamarin D] [Palese P] [Fong Y] [Wong RJ]
Oncolytic specificity of newcastle disease virus is mediated by selectivity for apoptosis-resistant cells. May 2011 - J. Virol.; 85(12):1098-5514 [PMID:21471241] [Mansour M] [Palese P] [Zamarin D]
Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer. Nov 2010 - Head Neck:1097-0347 [PMID:21053297] [Li P] [Chen CH] [Li S] [Givi B] [Yu Z] [Zamarin D] [Palese P] [Fong Y] [Wong RJ]
Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses. Apr 2009 - Mol. Ther.; 17(4):1525-0024 [PMID:19209145] [Zamarin D] [Martínez-Sobrido L] [Kelly K] [Mansour M] [Sheng G] [Vigil A] [García-Sastre A] [Palese P] [Fong Y]
